Could A Rare, Deadly ‘Superbug’ Fungus Be Gaining A Foothold?
The Centers for Disease Control and Prevention says the number of confirmed cases of Candida auris in the U.S. has climbed from seven in 2016 to at least 200.
The independent source for health policy research, polling, and news.
7,061 - 7,080 of 15,449 Results
The Centers for Disease Control and Prevention says the number of confirmed cases of Candida auris in the U.S. has climbed from seven in 2016 to at least 200.
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”
More low-income people now live in suburbs than in cities or rural areas, putting a strain on local health services. Suburbs, which traditionally have had fewer resources or infrastructure, are scrambling to catch up.
A new social movement in the U.S. tackles the stigma of living with Alzheimer’s.
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.
A report issued by the National Academy for State Health Policy shows a small decrease in sign-ups last fall, but states running their own marketplaces did better than those that don’t.
A package of mental health bills in California aims to ensure that all new moms are screened for postpartum depression and that more support is available for those who struggle with the malady.
Sickle cell disease receives far less attention from the medical establishment and the press than other illnesses that affect far fewer people.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Environmental health professor Don Milton is studying how the flu — and other dangerous infections — are spread. The close quarters of dorm rooms and cafeterias at the University of Maryland provide him with a steady supply of research subjects.
President Donald Trump’s decision to stop paying cost-sharing reduction subsidies means the federal government will reduce its funding of the Basic Health Program that provides low-cost coverage to more than 800,000 low-income people in those two states.
The centers, which serve 27 million people, get about 20 percent of their funding from the federal government. But that revenue is slated to end on March 31.
Two women, 80 and 91, from opposite poles, agree on the art of aging.
Fentanyl, a significant cause of overdoses and deaths across the country, has begun showing up in California street drugs. State health officials have responded with a bold but controversial policy: paying for test strips so users can check their stash.
HHS officials sign off on a plan that could lock out for six months thousands of people who fail to get their paperwork done promptly.
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
The state branded its Medicaid expansion with some key conservative policies, and officials and advocates across the country are keenly watching the results.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.
© 2026 KFF